Czech company offers expert system for the interpretation of biomarkers, hormones, and other laboratory results in oncology, thyreology and reproduction endokrinology under license or commercial agency agreement

A Czech company experienced in medical sector and ICT has developed software for biomarker tumour diagnosis. Medical expert system is based on: 1. The mathematical models based on the original algorithms (based on the fuzzy Bayesian classifier, data curve fitting and bivariate failure-time model with one hidden failure). 2. The unique database of data collected from more than 90,000 patients. 3. From ICT point of view, it is cloud software, SaaS model, based on Python programming language using WSGI interface and Advanced Encryption Standard (AES) for transferring sensitive data. Software could be implemented to standard laboratory information and management systems (LIMS). Model parameters are estimated based on statistical processing of a suitable reference files of thousands of patients, taking into consideration information from the literature and from experts in the given field. The models also consider epidemiological data, in particular incidence and prevalence of illness. Expert system allows physicians effectively use information obtained through laboratory testing together with some clinical data and to summarize it as probabilities of illnesses and clinical status. Software provides physicians with a selection of blood markers to determine a specific diagnosis, i.e teach the physician how to use tumor markers and hormones properly. Company is looking for partners from medical sector which could implement the expert system or producer of eHealth product to buy the software solution under license agreement or experienced software seller to cooperate under commercial agency agreement.